BioCurie
PrivateLast Round
Grant
Mar 12, 2026
Total Funding Raised
$11.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioCurie operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Grant round in March 2026.
BioCurie is a TechBio company that develops an AI-driven software platform to optimize the manufacturing and development of cell, gene, and RNA therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Healthcare Analytics, Smart Manufacturing
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCurie Comparables
Compare BioCurie with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AiCella | 81% | |
| DataHow AG | 81% | |
| BioRaptor | 78% |
For institutional investors. Book with your work email.
BioCurie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 12, 2026 | ||||
| Seed | Oct 14, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioCurie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Seed |
| Delaware Division of Small Business | Grant |
| Cure by Deerfield | Seed |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 295% MoM, reaching 2.2K.
- May 27, 2026
Grew 38% QoQ, from 8 to 11 employees.
For institutional investors. Book with your work email.
BioCurie Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioCurie's valuation, stock price, and market status.
Is BioCurie a public or private company?
BioCurie is a private company.
What is the current stock price of BioCurie?
BioCurie is a private company, so its shares have no public market price. Caplight tracks BioCurie's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioCurie worth (valuation)?
Valuation information for BioCurie is not publicly available.
Can I buy BioCurie stock?
BioCurie shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioCurie's last funding round?
BioCurie's most recent funding round was Grant on March 12, 2026.
Who are the main investors in BioCurie?
Key investors in BioCurie include Creative Destruction Lab, Delaware Division of Small Business, Cure by Deerfield, ARPA-H.
Will BioCurie IPO soon?
No public IPO plans have been announced for BioCurie.
How can I track BioCurie secondary market activity?
Caplight tracks bids, offers, and trades in BioCurie's shares on secondary markets.